U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208073

Marketing Status: Prescription
Active Ingredient: LIFITEGRAST
Proprietary Name: XIIDRA
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 5%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N208073
Product Number: 001
Approval Date: Jul 11, 2016
Applicant Holder Full Name: BAUSCH AND LOMB INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top